The two companies have entered an agreement in which Danaher Corporation will acquire Abcam for $24 per share in cash. The transaction has been unanimously approved and recommended by the Abcam Board of Directors and unanimously approved by the Danaher Board of Directors. Founded in 1998 and headquartered in Cambridge, UK, Abcam provides antibodies, reagents, […]
